Brief: Glenmark Life Sciences Q2 Profit 953.2 Mln Rupees
24/10/2024 13:59
Oct 24 (Reuters) - Glenmark Life Sciences Ltd GLEM.NS :
* Q2 PROFIT 953.2 MILLION RUPEES
* Q2 REVENUE FROM OPERATIONS 5.07 BILLION RUPEES
Source text for Eikon: ID:nNSE6c2tF7
Further company coverage: GLEM.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alivus Life Sciences
See all newsBrief: Alivus Life Sciences Incorporates Subsidiary Alivus Life Sciences Do Brasil Ltda In Brazil
Brief: Alivus Life Sciences To Buy 76% Stake In Iqgen-X Pharma For Approx 91.2 Million Rupees
India's Alivus rises to 15-month high as brokerages optimistic about drugmaker's annual outlook
India's Alivus Life Sciences rises after quarterly profit increase
Brief: Alivus Life Sciences Ltd March-Quarter Profit 1.63 Billion Rupees